Injectable Scaffolds for Adipose Tissue Reconstruction.

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Tissue Engineering

Background:

• Autologous fat grafting is standard for soft tissue reconstruction but faces limitations like graft resorption and donor site morbidity.
• Developing injectable scaffolds is key to overcoming these limitations for larger volume reconstructions.
• Current scaffolds aim to mimic native adipose tissue's biological, structural, and mechanical properties.

Purpose of the Study:

• To review current injectable scaffolds for soft tissue volume restoration.
• To emphasize their translational potential and future directions in adipose tissue engineering.
• To address challenges in creating reliable soft tissue substitutes for large-volume reconstruction.

Main Methods:

• Review of natural, synthetic, and adipose extracellular matrix (aECM)-derived injectable scaffolds.
• Analysis of scaffold properties including biocompatibility, mechanical strength, degradation rates, and bioactivity.
• Evaluation of scaffolds for their potential to promote adipogenesis and angiogenesis.

Main Results:

• Natural scaffolds offer biocompatibility but have rapid degradation and poor mechanical strength.
• Synthetic scaffolds provide tunable properties but need biofunctionalization for cell integration.
• aECM-derived scaffolds combine biomimicry with biological cues, offering a promising
• off-the-shelf
• solution.

Conclusions:

• Injectable scaffolds are advancing soft tissue reconstruction, offering alternatives to autologous fat grafting.
• aECM-derived scaffolds represent a significant step towards clinically viable, large-volume soft tissue substitutes.
• Challenges remain in developing reliable, long-lasting soft tissue substitutes for extensive reconstruction needs.